Evidence map›Paper›PMID 32385253›Full record

ArticleNature communications2020

Tcf1

Suzanne P M Welten, Alexander Yermanos, Nicolas S Baumann, Franziska Wagen, Nathalie Oetiker, Ioana Sandu, Alessandro Pedrioli, Jennifer D Oduro, Sai T Reddy, Luka Cicin-Sain and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Adoptive T-cell therapy for virus-associated diseases.Clinical microbiology reviews · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Immune surveillance of cytomegalovirus in tissues.Cellular & molecular immunology · 2024
    Review
  12. Article
  13. Article
  14. Individual Epitope-Specific CD8Pathogens (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. TCF1 in T cell immunity: a broadened frontier.Nature reviews. Immunology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Suzanne P M WeltenInstitute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-8224-7984
Alexander Yermanos *Institute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zürich, Switzerland.
Nicolas S Baumann *Institute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zürich, Switzerland.
Franziska WagenInstitute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zürich, Switzerland.
Nathalie OetikerInstitute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zürich, Switzerland.
Ioana SanduInstitute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-4696-0683
Alessandro PedrioliInstitute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zürich, Switzerland.
Jennifer D OduroDepartment of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Hannover-Braunschweig Site, 38124, Braunschweig, Germany.
Sai T ReddyDepartment of Biosystems and Engineering, ETH Zürich, Mattenstrasse 26, 4058, Basel, Switzerland.
Luka Cicin-SainDepartment of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Hannover-Braunschweig Site, 38124, Braunschweig, Germany.ORCID http://orcid.org/0000-0003-3978-778X
Werner HeldDepartment of Oncology, University of Lausanne, 1066, Epalinges, Switzerland.ORCID http://orcid.org/0000-0003-3292-1536
Annette OxeniusInstitute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zürich, Switzerland. aoxenius@micro.biol.ethz.ch.ORCID http://orcid.org/0000-0002-2079-2354
ETH Zurich · CHHelmholtz Centre for Infection Research · DEUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytomegalovirus-based vaccine vectors offer interesting opportunities for T cell-based vaccination purposes as CMV infection induces large numbers of functional effector-like cells that accumulate in peripheral tissues, a process termed memory inflation. Maintenance of high numbers of peripheral CD8 T cells requires continuous replenishment of the inflationary T cell pool. Here, we show that the inflationary T cell population contains a small subset of cells expressing the transcription factor Tcf1. These Tcf1

Indexed as

AnimalsCD8-Positive T-LymphocytesCell ProliferationClone CellsHerpesviridae InfectionsImmunologic MemoryInterferon Type IInterleukin-12Mice, Inbred C57BLMuromegalovirusPhenotypeT Cell Transcription Factor 1T-LymphocytesInterferon Type IInterleukin-12T Cell Transcription Factor 1

Identifiers

PMID32385253
PMCPMC7211020
OpenAlexW3021611140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.